Carlson T H
Department of Pathology, University of New Mexico, School of Medicine, Albuquerque 87131.
Thromb Res. 1989 Aug 15;55(4):471-80. doi: 10.1016/0049-3848(89)90055-8.
Studies of radioiodinated antithrombin III kinetic behavior in vivo have shown that a pool of this protein partitions into a vascular compartment that could be the result of antithrombin III interaction with heparin-related glycosaminoglycans present on the vessel wall (J. Clin. Invest. 74, 191-191, 1984). As this partitioning was demonstrated by the rapid initial clearance of the labeled antithrombin III, new studies were performed to determine the effect on this clearance of large doses of intravenously administered heparin. In addition, as previous studies had shown unequal clearance rates for tracer-labeled antithrombin III isoforms differing in affinity for heparin, the effect of heparin treatment was assessed for each isoform. Comparison of data from heparin-treated and control animals demonstrated that heparin markedly decreased the clearance rates for each of the *I-labeled antithrombin III isoforms. Heparin also abolished the difference in *I-antithrombin III isoform plasma-clearance rates, and this effect rapidly disappeared after treatment was discontinued. Inhibition by heparin of the initial clearance of *I-labeled ATIII isoforms is the first direct evidence from in vivo studies for the notion that the pool of antithrombin III which is in rapid equilibrium with the plasma pool is, at least in part, the result of the interaction of antithrombin III with vessel wall heparin-related glycosaminoglycans.
体内放射性碘化抗凝血酶III动力学行为的研究表明,该蛋白的一部分会进入血管腔室,这可能是抗凝血酶III与血管壁上存在的肝素相关糖胺聚糖相互作用的结果(《临床研究杂志》74, 191 - 191, 1984年)。由于这种分配是通过标记的抗凝血酶III的快速初始清除来证明的,因此进行了新的研究以确定大剂量静脉注射肝素对这种清除的影响。此外,由于先前的研究表明,对肝素亲和力不同的示踪剂标记抗凝血酶III同工型的清除率不相等,因此对每种同工型评估了肝素治疗的效果。肝素治疗组和对照组动物的数据比较表明,肝素显著降低了每种¹²⁵I标记的抗凝血酶III同工型的清除率。肝素还消除了¹²⁵I - 抗凝血酶III同工型血浆清除率的差异,并且在停止治疗后这种效果迅速消失。肝素对¹²⁵I标记的抗凝血酶III同工型初始清除的抑制作用是体内研究首次直接证明与血浆池处于快速平衡的抗凝血酶III池至少部分是抗凝血酶III与血管壁肝素相关糖胺聚糖相互作用的结果这一观点。